CINCINNATI--(BUSINESS WIRE)--June 26, 2006--FORTUNE Small Business
announced today that Meridian Bioscience, Inc. (NASDAQ:VIVO) has been
ranked 66 on the sixth annual FSB 100 list of the fastest growing
small companies in America. The list, which is comprised of public
companies, appears in the July/August issue of FORTUNE Small Business
and is available at FSB.com.
John A. Kraeutler, President and Chief Operating Officer, stated,
"We would like to thank FORTUNE Small Business for recognizing
Meridian Bioscience. This achievement is a tribute to our dedicated
employees and our loyal customers around the world. We will strive to
continue to develop clinically significant diagnostic and therapeutic
tools that improve the delivery of superior healthcare and, that
consistently deliver optimal shareholder value."
California tops the list of the states with the most companies on
the FORTUNE Small Business 100 with 18 companies, followed by Texas
with 12, New York with eight and New Jersey with seven.
To compile the sixth annual list, FORTUNE Small Business asked
financial research firm Zacks to rank public companies with revenues
less than $200 million and a stock price of more than $1, based on
their percentage growth in earnings, revenue, and stock performance
over the past three years. Banks and real estate firms were excluded.
Meridian is a fully integrated life science company that
manufactures, markets and distributes a broad range of innovative
diagnostic test kits, purified reagents and related products and
offers biopharmaceutical enabling technologies. Utilizing a variety of
methods, these diagnostic products and tests provide accuracy,
simplicity and speed in the early diagnosis and treatment of common
medical conditions, such as gastrointestinal, viral, urinary and
respiratory infections. Meridian diagnostic products are used outside
of the human body and require little or no special equipment. The
Company's products are designed to enhance patient well-being while
reducing the total outcome costs of healthcare. Meridian has strong
market positions in the areas of gastrointestinal and upper
respiratory infections, serology, parasitology and fungal disease
diagnosis. In addition, Meridian is a supplier of rare reagents,
specialty biologicals and related technologies used by
biopharmaceutical companies engaged in research for new drugs and
vaccines. The Company markets its products and technologies to
hospitals, reference laboratories, research centers, veterinary
testing centers, physician offices, diagnostics manufacturers and
biotech companies in more than 60 countries around the world. The
Company's shares are traded through Nasdaq's National Market, symbol
VIVO. Meridian's website address is www.meridianbioscience.com.
CONTACT: Meridian Bioscience, Inc.
John A. Kraeutler, 513-271-3700
SOURCE: Meridian Bioscience, Inc.